Measurement of Exhaled Propofol (PIAG1)

University of Erlangen-Nürnberg Medical School

Status: Terminated

Conditions: Anaesthesia With Propofol

Study type: Observational

Funder types: Other

Identifiers

NCT02199067

PIAG1

Details and patient eligibility

About

Propofol is a common intravenous anaesthetic drug used for anaesthesia induction and for permanent infusion to maintain anaesthesia (total intravenous anaesthesia). Different to the volatile anaesthetics (feedback concentrations in exhaled breathing gas) piloting of an total intravenous anaesthesia with propofol is done only by experience of the anaesthetist or according to pharmacokinetic models. In this study we want to investigate if the exhaled fraction of propofol is a potential measurement parameter for piloting anaesthesia. Exhaled propofol will be measured with an electrochemical sensor developed by "Drägerwerk AG & Co. KGaA". Exhaled propofol levels will be compared with the corresponding arterial serum concentrations of propofol. Furthermore we investigate the correlation of exhaled propofol levels with the Bispectral Index (BIS).

Enrollment: 20 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA (American Society of Anaesthesiologists) classification I & II
• Body-Mass-Index < 35
• elective surgery with the necessity of an arterial catheter

Exclusion criteria

• chronic obstructive lung disease
• bronchial asthma
• smokers with more than 5 packyears
• peripheral artery occlusive disease
• diabetes mellitus